Aragen plans 500 kiloliters of new contract drug manufacturing capacity
The Economic Times reports that Aragen Life Sciences is increasing investment in complex drug types, with plans for added small-molecule manufacturing capacity and a biologics facility.
TLDR
Aragen Life Sciences plans 500 kiloliters of new contract development and manufacturing capacity, The Economic Times reports. Its expansion plans include small-molecule capacity and a biologics facility. The report connects the move with global drugmakers seeking supply-chain alternatives outside China.
Combined views
5.7K
1 Source, first seen 9d ago
2 likes1 reposts